The literature indicates that SMARCA4-deficient NSCLC primarily affects male individuals around the age of 60, especially smokers, and is characterized by large, aggressive tumors with high proliferation indices, evidenced by increased Ki-67 levels (7). The gene discussed is SMARCA4; the disease is non-small cell lung carcinoma.